有希望的艾滋病治疗新药和药物靶点

Future Prescriber Pub Date : 2013-12-09 DOI:10.1002/fps.108
Sarah Duncan MRCP, Dip HIV, Lucy Dorrell DM, FRCP Nuffield
{"title":"有希望的艾滋病治疗新药和药物靶点","authors":"Sarah Duncan MRCP, Dip HIV,&nbsp;Lucy Dorrell DM, FRCP Nuffield","doi":"10.1002/fps.108","DOIUrl":null,"url":null,"abstract":"<p>The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long-term control of HIV are side-effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"14 2","pages":"13-16"},"PeriodicalIF":0.0000,"publicationDate":"2013-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.108","citationCount":"1","resultStr":"{\"title\":\"Promising new drugs and drug targets for HIV treatment\",\"authors\":\"Sarah Duncan MRCP, Dip HIV,&nbsp;Lucy Dorrell DM, FRCP Nuffield\",\"doi\":\"10.1002/fps.108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long-term control of HIV are side-effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.</p>\",\"PeriodicalId\":100566,\"journal\":{\"name\":\"Future Prescriber\",\"volume\":\"14 2\",\"pages\":\"13-16\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-12-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/fps.108\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fps.108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

自从采用抗逆转录病毒联合疗法(cART)以来,与艾滋病毒有关的死亡率已经下降,及早开始治疗的人的预期寿命现在正在接近一般人群的预期寿命。然而,维持艾滋病毒长期控制的关键问题是副作用和便利性/依从性。这篇综述将讨论现有的和最近引入的治疗方法,以及目前正在研究的潜在的未来治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Promising new drugs and drug targets for HIV treatment

The mortality associated with HIV has declined since the introduction of combination antiretroviral therapy (cART) and life expectancy for those who begin treatment early enough is now approaching that of the general population. However, key concerns in maintaining long-term control of HIV are side-effects and convenience/adherence. This review will discuss the available and recently introduced treatments, and the potential future therapies currently under investigation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信